Publication | Closed Access

Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma

OncologyPhase 3Oral Mucositis PainOral CavityPharmacologyPlacebo-controlled StudyMedicineOral Cancer